Treating Lung Disease in Nashville

Nashville  is home to many progressive medical companies. One such medical treatment facility, the Lung Institute, is leading the new field of adult cellular therapies for lung disease.

Adult Cellular Treatment

Adult cells can be utilized in any organ in the body since cells are able to mimic any differentiated cell. Since they are capable of self-renewing indefinitely, they can divide many times and can specialize to promote the healing of organs, such as lungs, while still sustaining the original cell.

While there are many options for the type of stem cell used in the science, the Lung Institute only treats with adult autologous cells. This means the cells are directly coming from a patient’s own body and are later infused back into the same patient. This decreases the possibility of rejection and eliminates any possible controversy associated with cells. Through regenerative medicine, cells replicate continuously, the lungs grow stronger, and patients are able to breathe easier and live better.

Cellular Therapy for Lung Disease

Lung disease like chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, interstitial lung disease and pulmonary fibrosis can be treated with cells. Depending on the condition being treated, the forms of cells used by the Lung Institute are autologous, and can be found in adult bone marrow and/or the patient’s peripheral blood. Cells have the ability for self renewal and replication, capable of forming any type of tissue or organ in the body.

Venous Cellular Treatment – Some patients may undergo a venous cellular therapy. This purely blood-derived treatment is less invasive. In addition, follow-up treatments may need to be performed more often for optimal results.

If you or a loved one suffers from a lung disease and want to learn more about treatment optionscontact us or call 888-745-6697.

*For more information, go to

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.